期刊文献+

胰岛素抵抗大鼠脂肪组织chemerin mRNA的表达和意义 被引量:5

Expressions and Significance of chemerin mRNA in Adipose Tissue of Insulin Resistant Rats
下载PDF
导出
摘要 目的探讨胰岛素抵抗大鼠脂肪组织中脂肪因子chemerin mRNA的表达情况及其与胰岛素抵抗之间的关系。方法采用高脂饲料喂养建立胰岛素抵抗大鼠模型,将30只雄性SD大鼠随机分为正常饮食组(NC,n=15)和高脂饮食组(HF,n=15),喂养10周后,以大鼠清醒状态下正常血糖-高血浆胰岛素钳夹技术进行评估,处死后取肾周脂肪组织,应用Real-time PCR方法检测大鼠脂肪组织中chemerin mRNA的表达水平。结果 (1)与NC组比较,HF组60~120 min的平均葡萄糖输注率(GIR60~120)明显降低[分别为(13.87±1.45)mg·kg-·1min-1和(24.10±2.87)mg·kg-·1min-1,P<0.05];(2)与NC组比较,HF组大鼠脂肪组织中chemerin mRNA的表达明显升高[分别为(1.86±1.02)和(0.92±0.32),P<0.01]。结论胰岛素抵抗大鼠脂肪组织chemerin mRNA升高,提示脂肪因子chemerin可能参与胰岛素抵抗的发生。 Objective To investigate the expressions of chemerin mRNA in adipose tissue of insulin resistant rats and the relationship be- tween them. Methods Insulin resistant rats were induced by high-fat diet feeding. Thirty male SD rats were randomly divided into two groups fed with either basic chow (NC, n = 15 ) or high-fat diet (HF, n =15 ) for 10 weeks, then assessed by euglycemic-hyperinsulinemia clamp technique. Rats were sacrificed and taken the perinephrit adipose tissue.The chemerin mRNA expression in adipose tissue was tested by real-time PCR. Results (1) The glucose infusion rate (GIR60-120) was significantly decreased in HF group compared with control group,GIR60-120 (13.87+-1.45 mg.kg-1.min-1 vs 24.10+-2.87 mg.kg-1.min-1 ,P 〈 0.05). (2)The chemerin mRNA expression in adipose tissue was significantly increased in HF group compared with control group ( 1.86+-1.02 vs 0.92+-0.32,P 〈 0.01 ). Conclusion The increased expression of chemerin mRNA in adipose tissue of insulin resistant rats showed that cheraerin might be involved in insulin resistance.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2012年第1期35-37,共3页 Journal of China Medical University
基金 辽宁省科学技术计划项目(2009225029) 辽宁省教育厅高校科研计划(L20105972009A715)
关键词 CHEMERIN 脂肪组织 胰岛素抵抗 大鼠 清醒状态 正常血糖-胰岛素钳夹技术 chemerin adipose tissue insulin resistahoe rat waking state euglycemie-hyperinsulinemie clamp
  • 相关文献

参考文献3

二级参考文献56

  • 1都健,赵晓娟,刘国良.胰岛素抵抗大鼠内皮依赖性血管舒张功能研究[J].中华内分泌代谢杂志,2003,19(4):313-316. 被引量:23
  • 2Delgado MB, Clark-Lewis I, Loetscher P, Langen H, Thelen M, Baggiolini M and Wolf M. Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes. Eur J immunol 2001, 31: 699-707.
  • 3Davis DA, Singer KE, De La Luz Sierra M, Narazaki M, Yang F, Fales HM and Yarchoan R, et al. Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-lalpha in the circulation. Blood 2005, 105:4561 4568.
  • 4De La Luz Sierra M, Yang F, Narazaki M, Salvucci O, Davis D, Yarchoan R and Zhang HH, et al. Differential processing of stromalderived factor-lalpha and stromal-derived factor-lbeta explains functional diversity. Blood 2004, 103:2452 -2459.
  • 5Wittamer V, Gregoire F, Robberecht P, Vassart G, Communi D and Parmentier M. The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. J Biol Chem 2004, 279:9956 9962.
  • 6Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, Doran J and Hendrick AG, et al. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med 2008, 205:767- 775.
  • 7Wittamer V, Bondue B, Guillabert A, Vassart G, Parmentier M and Communi D. Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity. J Immunol 2005, 175: 487- 493.
  • 8Myles T, Nishimura T, Yun TH, Nagashima M, Morser J, Patterson AJ and Pearl RG, et al. Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation. J Biol Chem 2003, 278: 51059-51067.
  • 9Kulig P, Zabel BA, Dubin G, Allen S J, Ohyama T, Potempa J and Handel TM, et al. Staphylococcus aureus-derived staphopain B, a potent cysteine protease activator of plasma chemerin. J lmmtmol 2007, 178:3713 3720.
  • 10Parolini S, Santoro A, Marcenaro E, Luini W, Massardi L, Facchetti F and Communi D, et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007, 109: 3625- 3632.

共引文献25

同被引文献51

  • 1赵维纲,朱惠娟.肥胖致胰岛素抵抗和高血糖的机制、治疗及评测[J].中国医学科学院学报,2010,32(1):7-12. 被引量:24
  • 2焦谊,常曦,王丽凤,李俊红,关亚群.重组chemerin蛋白对3T3-L1脂肪细胞visfatin、MCP-1基因表达的影响[J].中国老年学杂志,2014,34(2):414-417. 被引量:1
  • 3No authors listed.Correction:effects of an angiotensin-converting-enzyme inhibitor,ramipril,on cardiovascular events in high-risk patients[J].N Engl J Med,2000,342(18):1376.
  • 4Alenina N,Bader M,Walther T.,et al Imprinting of the murine MAS protooncogene is restricted to its antisense RNA[J].Biochem Biophys Res Commun,2002,290(3):1072-1078.
  • 5Strazzullo P,Galletti F.Impact of the renin-angiotensin system on lipid and carbohydrate metabolism[J].Curr Opin Nephrol Hypertens,2004,13(3):325-332.
  • 6Muscogiuri G,Chavez A O,Gastaldelli A,et al.The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention[J].Curr Vasc Pharmacol,2008,6(4):301-312.
  • 7Wei Y,Sowers J R,Nistala R,et al.Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells[J].J Biol Chem,2006,281(46):35137-35146.
  • 8Giani J F,Gironacci M M,Munoz M C,et al.Angiotensin-(1 7) stimulates the phosphorylation of JAK2,IRS-1 and Akt in rat heart in vivo:role of the AT1 and Mas receptors[J].Am J Physiol Heart Circ Physiol,2007,293(2):H1154-1163.
  • 9Santos S H,Fernandes L R,Mario E G,et al.Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism[J].Diabetes,2008,57(2):340-347.
  • 10Niu M J,Yang J K,Lin S S,et al.Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice[J].Endocrine,2008,34(1-3):56-61.

引证文献5

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部